Alan B. Miller, M.D.

Alan B. Miller M.D.

Department: Department of Medicine
Business Phone: (904) 244-2655
Business Email: alan.miller@jax.ufl.edu

Board Certifications

  • Internal Medicine
  • Cardiovascular Disease

Clinical Profile

Specialties
  • Cardiovascular Disease
Interests
  • Clinical Special Interests: Heart failure

Publications

2021
Causes of Cardiovascular Hospitalization and Death in Patients With Transthyretin Amyloid Cardiomyopathy (from the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial [ATTR-ACT]).
The American journal of cardiology.148():146-150[DOI] 10.1016/j.amjcard.2021.02.035.[PMID] 33667442.
2021
Effect of Empagliflozin on the Clinical Stability of Patients With Heart Failure and a Reduced Ejection Fraction: The EMPEROR-Reduced Trial.
Circulation.143(4):326-336[DOI] 10.1161/CIRCULATIONAHA.120.051783.[PMID] 33081531.
2021
Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction: EMPEROR-Preserved Trial.
Circulation.144(16):1284-1294[DOI] 10.1161/CIRCULATIONAHA.121.056824.[PMID] 34459213.
2021
Remote Hemodynamic Monitoring Equally Reduces Heart Failure Hospitalizations in Women and Men in Clinical Practice
Circulation-Heart Failure.14(6):-[DOI] 10.1161/CIRCHEARTFAILURE.120.007892.[PMID] .
2020
Cause of Death in Patients With Acute Heart Failure: Insights From RELAX-AHF-2.
JACC. Heart failure.8(12):999-1008[DOI] 10.1016/j.jchf.2020.09.010.[PMID] 33189635.
2018
Prognostic utility of NT-proBNP greater than 70,000 pg/mL in patients with end stage renal disease.
Journal of geriatric cardiology : JGC.15(7):476-478[DOI] 10.11909/j.issn.1671-5411.2018.07.002.[PMID] 30364747.
2016
Ten-Year Outcomes After Coronary Artery Bypass Grafting According to Age in Patients With Heart Failure and Left Ventricular Systolic Dysfunction: An Analysis of the Extended Follow-Up of the STICH Trial (Surgical Treatment for Ischemic Heart Failure).
Circulation.134(18):1314-1324[DOI] 10.1161/CIRCULATIONAHA.116.024800.[PMID] 27573034.
2015
A novel method to predict the proportional risk of sudden cardiac death in heart failure: Derivation of the Seattle Proportional Risk Model.
Heart rhythm.12(10):2069-77[DOI] 10.1016/j.hrthm.2015.06.039.[PMID] 26142301.
2015
Clinical characteristics and outcomes of patients with and without diabetes in the Surgical Treatment for Ischemic Heart Failure (STICH) trial.
European journal of heart failure.17(7):725-34[DOI] 10.1002/ejhf.288.[PMID] 26011509.
2015
Pulmonary hypertension related to left heart disease: insight from a wireless implantable hemodynamic monitor.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.34(3):329-37[DOI] 10.1016/j.healun.2014.04.014.[PMID] 24999252.
2015
The Hospitalization Burden and Post-Hospitalization Mortality Risk in Heart Failure With Preserved Ejection Fraction: Results From the I-PRESERVE Trial (Irbesartan in Heart Failure and Preserved Ejection Fraction).
JACC. Heart failure.3(6):429-441[DOI] 10.1016/j.jchf.2014.12.017.[PMID] 25982110.
2014
Effect of Serelaxin On Mode of Death in Acute Heart Failure Results From the Relax-Ahf Study
Journal of the American College of Cardiology.64(15):1591-1598[DOI] 10.1016/j.jacc.2014.05.071.[PMID] 25301463.
2014
Pa32540 (a Coordinated-Delivery Tablet of Enteric-Coated Aspirin 325 Mg and Immediate-Release Omeprazole 40 Mg) Versus Enteric-Coated Aspirin 325 Mg Alone in Subjects At Risk for Aspirin-Associated Gastric Ulcers: Results of Two 6-Month, Phase 3 Studies
American heart journal.168(4):495+-502.e4[DOI] 10.1016/j.ahj.2014.05.017.[PMID] 25262259.
2013
Association between bilirubin and mode of death in severe systolic heart failure.
The American journal of cardiology.111(8):1192-7[DOI] 10.1016/j.amjcard.2012.12.048.[PMID] 23351460.
2013
Association of cardiac events with coronary artery disease detected by 64-slice or greater coronary CT angiography: a systematic review and meta-analysis.
International journal of cardiology.169(2):112-20[DOI] 10.1016/j.ijcard.2013.08.096.[PMID] 24090745.
2013
Association of low body temperature and poor outcomes in patients admitted with worsening heart failure: a substudy of the Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) trial.
European journal of heart failure.15(12):1382-9[DOI] 10.1093/eurjhf/hft113.[PMID] 23858000.
2013
Cardiovascular safety of varenicline: patient-level meta-analysis of randomized, blinded, placebo-controlled trials.
American journal of therapeutics.20(3):235-46[DOI] 10.1097/MJT.0b013e31828d455b.[PMID] 23615317.
2013
Effect of bucindolol on heart failure outcomes and heart rate response in patients with reduced ejection fraction heart failure and atrial fibrillation.
European journal of heart failure.15(3):324-33[DOI] 10.1093/eurjhf/hfs181.[PMID] 23223178.
2013
Why Are Patients With Heart Failure and Preserved Ejection Fraction Hospitalized? Data From I-Preserve
Circulation.128(22, S):-[DOI] .[PMID] .
2012
A case of caffeine-induced coronary artery vasospasm of a 17-year-old male.
Cardiovascular toxicology.12(2):175-9[DOI] 10.1007/s12012-011-9152-9.[PMID] 22231478.
2012
Combinatorial pharmacogenetic interactions of bucindolol and β1, α2C adrenergic receptor polymorphisms.
PloS one.7(10):e44324-[DOI] 10.1371/journal.pone.0044324.[PMID] 23071495.
2012
Impact of Remote, Wireless Pulmonary Artery Hemodynamic Monitoring in Patients With Atrial Fibrillation and Chronic Heart Failure: Insights From the Champion Trial
Journal of the American College of Cardiology.59():E868-[DOI] .[PMID] .
2012
The Safety of An Adenosine A(1)-Receptor Antagonist, Rolofylline, in Patients With Acute Heart Failure and Renal Impairment Findings From Protect
Drug Safety.35():233-244[DOI] .[PMID] .
2011
Body Mass Index and Adverse Cardiovascular Outcomes in Heart Failure Patients With Preserved Ejection Fraction Results From the Irbesartan in Heart Failure With Preserved Ejection Fraction (I-Preserve) Trial
Circulation-Heart Failure.4(3):324-331[DOI] 10.1161/CIRCHEARTFAILURE.110.959890.[PMID] 21350053.
2011
Mode of death and hospitalization from the Second Follow-up Serial Infusions of Nesiritide (FUSION II) trial and comparison of clinical events committee adjudicated versus investigator reported outcomes.
The American journal of cardiology.108(10):1449-57[DOI] 10.1016/j.amjcard.2011.06.065.[PMID] 21890092.
2011
The relationship between aortic stiffness and E/A filling ratio and myocardial strain in the context of left ventricular diastolic dysfunction in heart failure with normal ejection fraction: insights from magnetic resonance imaging.
Magnetic resonance imaging.29(9):1222-34[DOI] 10.1016/j.mri.2011.08.003.[PMID] 21907518.
2010
Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: results from Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) program.
American heart journal.159(5):841-849.e1[DOI] 10.1016/j.ahj.2010.02.023.[PMID] 20435194.
2010
Determination of hospitalization type by investigator case report form or adjudication committee in a large heart failure clinical trial (β-Blocker Evaluation of Survival Trial [BEST]).
American heart journal.160(4):649-54[DOI] 10.1016/j.ahj.2010.07.004.[PMID] 20934558.
2010
Implantable cardioverter-defibrillators in patients hospitalized for heart failure with chronically reduced left ventricular ejection fraction.
American journal of therapeutics.17(4):e78-87[DOI] 10.1097/MJT.0b013e3181e70a65.[PMID] 20634650.
2010
Importance of blood pressure control in left ventricular mass regression.
Journal of the American Society of Hypertension : JASH.4(6):302-10[DOI] 10.1016/j.jash.2010.09.003.[PMID] 20980215.
2010
Measuring aortic pulse wave velocity using high-field cardiovascular magnetic resonance: comparison of techniques.
Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.12(1):26-[DOI] 10.1186/1532-429X-12-26.[PMID] 20459799.
2010
Mode of Death in Patients With Heart Failure and a Preserved Ejection Fraction Results From the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-Preserve) Trial
Circulation.121(12):1393-1405[DOI] 10.1161/CIRCULATIONAHA.109.909614.[PMID] 20231531.
2009
Blocking aldosterone in heart failure.
Therapeutic advances in cardiovascular disease.3(5):379-85[DOI] 10.1177/1753944709341300.[PMID] 19661156.
2009
Prospective assessment of the occurrence of anemia in patients with heart failure: results from the Study of Anemia in a Heart Failure Population (STAMINA-HFP) Registry.
American heart journal.157(5):926-32[DOI] 10.1016/j.ahj.2009.01.012.[PMID] 19376323.
2009
Sotalol as adjunctive therapy to implantable cardioverter-defibrillators in heart failure patients.
Congestive heart failure (Greenwich, Conn.).15(3):144-7[DOI] 10.1111/j.1751-7133.2009.00062.x.[PMID] 19522964.
2009
Understanding heart failure with preserved ejection fraction: clinical importance and future outlook.
Congestive heart failure (Greenwich, Conn.).15(4):186-92[DOI] 10.1111/j.1751-7133.2009.00063.x.[PMID] 19627293.
2008
Association of Heart Failure Class and Left Ventricular Dyssynchrony Measured By Spect Imaging in Ischemic Systolic Heart Failure Patients
Journal of Cardiac Failure.14(6):S90-[DOI] 10.1016/j.cardfail.2008.06.246.[PMID] .
2008
Association of Ventricular Arrhythmia Therapy and Extent of Scarred Myocardium Measured By Single-Photon Emission Computed Tomography Imaging in Ischemic Systolic Heart Failure Patients
Journal of Cardiac Failure.14(6):S58-[DOI] 10.1016/j.cardfail.2008.06.306.[PMID] .
2008
Correlation of Ejection Fraction To Early Post-Discharge Sudden Death and All-Cause Mortality in the Everest Trial
.14():S71-[DOI] .[PMID] .
2008
Greater Anatomic and Electrical Interelectrode Distance Predicts Clinical Response To Chronic Resynchronization Therapy
Journal of the American College of Cardiology.51():A20-A21[DOI] .[PMID] .
2008
Pioglitazone and heart failure: results from a controlled study in patients with type 2 diabetes mellitus and systolic dysfunction.
Journal of cardiac failure.14(6):445-52[DOI] 10.1016/j.cardfail.2008.02.007.[PMID] 18672190.
2008
Post-Discharge Adjudicated Outcomes in Patients With Implantable Cardioverter-Defibrillators in the Everest Trial
Journal of Cardiac Failure.14(6):S72-[DOI] 10.1016/j.cardfail.2008.06.197.[PMID] .
2007
Aldosterone antagonism in heart failure.
Vascular health and risk management.3(5):605-9[DOI] .[PMID] 18078011.
2006
Images in cardiology: syncope: a case of vein graft rupture.
Clinical cardiology.29(11):512-[DOI] .[PMID] 17133851.
2006
The effect of statins in heart failure: beyond its cholesterol-lowering effect.
Journal of cardiac failure.12(6):473-8[DOI] .[PMID] 16911915.
2005
Congestive heart failure and atrial fibrillation: rhythm versus rate control.
Journal of cardiac failure.11(3):164-72[DOI] .[PMID] 15812742.
2003
Agents that stabilise atherosclerotic plaque.
Expert opinion on investigational drugs.12(10):1681-92[DOI] .[PMID] 14519087.
2002
Anticoagulation in patients with dilated cardiomyopathy and sinus rhythm: a critical literature review.
Journal of cardiac failure.8(1):48-53[DOI] .[PMID] 11862583.
2002
Renin-angiotensin system antagonism and lipid-lowering therapy in cardiovascular risk management.
Journal of the renin-angiotensin-aldosterone system : JRAAS.3(2):96-102[DOI] .[PMID] 12228849.
2001
Angiotensin receptor blockers and aldosterone antagonists in chronic heart failure.
Cardiology clinics.19(2):195-202, v[DOI] .[PMID] 11407105.
2001
Effect of lipid-lowering agents, angiotensin-converting enzyme inhibitors, and calcium antagonists on coronary disease risk.
American Journal of Cardiology.88(10A):21M-25M[DOI] .[PMID] 11705418.
2001
Is there a role for calcium channel blockers in congestive heart failure?
Current Cardiology Reports.3(2):114-8[DOI] .[PMID] 11177667.

Office Information

Academic Office
5th Floor, Ambulatory Care Center
655 West 8th Street, C35
Jacksonville, FL 32209
(904) 244-8232
alan.miller@jax.ufl.edu
Administrative Manager
Erika Jackson
(904) 244-2655
erika.jackson@jax.ufl.edu

Education

Medical Degree
1966 · University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
Internal Medicine Residency
1968 · Mount Sinai Hospital, Cleveland, OH, USA
Internal Medicine Residency
1971 · George Washington University School of Medicine, Washington, DC, USA
Cardiovascular Disease Fellowship
1972 · Huron Road Hospital, Cleveland, OH, USA
Cardiovascular Disease Fellowship
1973 · Cleveland Metropolitan General Hospital, Cleveland, OH, USA